Propel Bio Management, LLC Abeona Therapeutics Inc. Call Options Transaction History
Propel Bio Management, LLC
- $154 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABEO
# of Institutions
58Shares Held
28.6MCall Options Held
827KPut Options Held
44.5K-
Suvretta Capital Management, LLC New York, NY3.69MShares$22.5 Million0.65% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.47MShares$21.2 Million0.98% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$19.8 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.68MShares$16.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$11.9 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $36.3M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...